Why Corteva Stock Dropped on Thursday

Corteva stock plummeted 20.2% after missing Q3 earnings expectations, reporting $0.06 per share instead of the anticipated $0.10, with sales below $1.6 billion versus expected $1.8 billion. The miss was driven by rapid price declines in agricultural chemicals, particularly in Latin America where sales fell 28% year-over-year. Management expects challenging market conditions ahead, especially in Brazil, though full-year guidance remains between $0.76-$0.80 per share on an adjusted basis—below Wall Street's GAAP expectations of $0.82.

11/12/2026, 1:31 PM • The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC

Pomerantz LLP is investigating potential securities fraud claims on behalf of FMC Corporation investors. On October 15, 2026, FMC issued revised guidance showing significantly lower revenue expectations ($65-125M) and negative EBITDA ($510-565M), citing $625-675M in commercial actions to lower product prices. The announcement triggered a 30.53% stock price decline to $5.62 per share.

11/10/2026, 6:50 PM • GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC

Pomerantz LLP is investigating potential securities fraud claims against FMC Corporation following a significant stock price decline. On October 15, 2026, FMC issued revised guidance showing expected revenue between $65-125 million and negative EBITDA of $510-565 million, citing $625-675 million in commercial actions to lower product prices. The announcement caused FMC's stock to plummet 30.53% to $5.62 per share.

11/03/2026, 6:14 PM • GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC

Pomerantz LLP is investigating potential securities fraud claims against FMC Corporation following a significant stock price decline. On October 15, 2026, FMC issued revised guidance showing expected revenue between $65-125 million and negative EBITDA of $510-565 million, citing $625-675 million in commercial actions to lower product prices. The stock fell 30.53% to $5.62 per share on the disappointing guidance announcement.

10/27/2026, 6:56 PM • GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rafael Holdings, Inc. - RFL

Pomerantz LLP is investigating securities fraud claims on behalf of investors of Rafael Holdings, Inc. after the company announced that its Phase 3 clinical trial for Trappsol Cyclo failed to achieve statistical significance on its primary endpoint. Rafael's stock price fell 34.98% following the announcement on September 30, 2026. The law firm is also investigating similar claims against FMC Corporation and Neogen Corporation.

10/27/2026, 6:42 PM • GlobeNewswire

Why FMC Corporation Stock Just Crashed

FMC Corporation stock plummeted 32.4% after the company dramatically slashed its Q3 guidance. Revenue is now expected to fall $65-125 million (versus analyst expectations of $866.7 million), with adjusted EBITDA projected at negative $510-565 million. The collapse stems from weaker-than-weaker demand for agricultural chemicals, rapid market price declines due to generic competition, and FMC's need to slash prices by $625-675 million to clear inventory.

10/15/2026, 11:55 AM • The Motley Fool

Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin Off

Corteva (CTVA) surged 12% following a JPMorgan upgrade to Overweight with a $19 price target, implying 37% upside. The rally was fueled by the company's separation from Vylor and its inclusion in the S&P MidCap 400. Trading at 5.7x 2027 EBITDA, Corteva is positioned as a deep-value opportunity in crop protection, though legal liabilities from PFAS/PFOA concerns remain a risk factor.

10/06/2026, 5:12 PM • The Motley Fool

FMC Corp. Just Agreed to Sell Its India Commercial Business. Here's What That Means for the Stock in 2026.

FMC Corp. announced the sale of its India commercial business to Crystal Crop Protection Limited for $252 million to reduce debt and exit a problematic market. While a positive step, the sale will only reduce FMC's $4.5 billion debt load by 5.6%. The company faces significant headwinds including expired patents, weak agricultural markets, and declining revenue and EBITDA, with its turnaround dependent on new product development and potential acquisition.

05/28/2026, 6:05 AM • The Motley Fool

Why FMC Stock Was Sinking This Week

FMC stock fell 9% this week after announcing a $1.2 billion debt issuance of senior secured notes at 8% interest to refinance existing unsecured notes maturing in October at 3.2%. The higher borrowing costs and increased debt burden concerned investors, as the company will pay significantly more in interest expenses while adding to its overall debt load.

05/22/2026, 1:35 PM • The Motley Fool

Why This $4.4 Million Exit Looks Bearish for a Chemicals Stock Down 50%

Old North State Wealth Management completely exited its FMC Corporation position by selling 295,829 shares worth approximately $4.42 million in Q1 2026. The exit signals diminishing confidence in the company's recovery prospects, as FMC faces significant challenges including an 18% revenue decline, a $2.24 billion net loss, and further projected revenue declines for 2026. The stock has fallen 50% over the past year while underperforming the S&P 500.

04/17/2026, 12:27 PM • The Motley Fool

Why FMC Rallied in March, Even As Markets Fell

FMC Corporation rallied 16.8% in March despite a challenging 2025 due to two main factors: the Iran war creating a supply crunch in agricultural chemicals, and CEO announcements that 5-10 parties are interested in acquiring the company. However, the stock remains risky given high debt levels, industry cyclicality, and uncertain earnings impact from the supply crunch.

04/08/2026, 9:22 AM • The Motley Fool

Is an FMC Takeover on the Horizon? Here's What Investors Need to Know.

FMC Corporation announced in February it would pursue strategic options including a potential sale to unlock shareholder value. While the company has attracted interest from corporate and private equity buyers who believe in its product pipeline, recent financial results have been underwhelming with 2025 revenue down 5% and EPS down 14.9% year-over-year. The stock has surged 28% since the announcement, but analysts caution that much of the upside may already be priced in, and investors should be wary of betting on an uncertain acquisition outcome.

04/08/2026, 6:05 AM • The Motley Fool

Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday?

U.S. equity markets rebounded from seven-month lows on Monday as President Trump disclosed negotiations with Iran and Fed Chair Powell downplayed imminent rate hikes, calling tariffs a 'one-time price bump.' Treasury yields fell significantly, boosting financial, materials, and real estate sectors. Major indices gained broadly, with the S&P 500 up 0.7%, Dow up 1.1%, and Nasdaq 100 up 0.5%.

03/30/2026, 12:40 PM • Benzinga

Why FMC Corporation Rallied 20% This Week

FMC Corporation surged 19.6% this week as Middle East conflict disruptions boost fertilizer prices globally. A Citigroup analyst raised the price target from $14 to $15, citing supply constraints. Additionally, the company's CEO disclosed exploration of potential buyout offers from 5-10 interested parties. However, analysts caution that FMC remains a risky turnaround play given its 72% decline in 2025 and substantial debt load.

03/27/2026, 8:20 AM • The Motley Fool

Is FMC Stock Going to $15?

FMC Corporation's stock would need a 15% gain to reach $15, but the article suggests this is unlikely. The crop protection company faces significant headwinds with adjusted revenue declining 5% last year and management expecting another 5% decline this year. While the company is exploring strategic options including a potential sale, the weak fundamentals and lack of profitability make reaching the $15 target a difficult prospect without a major turnaround or acquisition.

03/24/2026, 8:20 AM • The Motley Fool